Emergence and Evolutionary Response of Vibrio cholerae to Novel Bacteriophage, Democratic Republic of the Congo

Democratic Republic of the Congo United States Vibrio cholerae antimicrobial resistance bacteria bacteriophages cholera viruses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
12 2022
Historique:
entrez: 23 11 2022
pubmed: 24 11 2022
medline: 26 11 2022
Statut: ppublish

Résumé

Cholera causes substantial illness and death in Africa. We analyzed 24 toxigenic Vibrio cholerae O1 strains isolated in 2015-2017 from patients in the Great Lakes region of the Democratic Republic of the Congo. Strains originating in southern Asia appeared to be part of the T10 introduction event in eastern Africa. We identified 2 main strain lineages, most recently a lineage corresponding to sequence type 515, a V. cholerae cluster previously reported in the Lake Kivu region. In 41% of fecal samples from cholera patients, we also identified a novel ICP1 (Bangladesh cholera phage 1) bacteriophage, genetically distinct from ICP1 isolates previously detected in Asia. Bacteriophage resistance occurred in distinct clades along both internal and external branches of the cholera phylogeny. This bacteriophage appears to have served as a major driver for cholera evolution and spread, and its appearance highlights the complex evolutionary dynamic that occurs between predatory phage and bacterial host.

Identifiants

pubmed: 36417939
doi: 10.3201/eid2812.220572
pmc: PMC9707599
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2482-2490

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI138554
Pays : United States

Références

PLoS Negl Trop Dis. 2020 Apr 20;14(4):e0007642
pubmed: 32310947
Nature. 2013 Feb 28;494(7438):489-91
pubmed: 23446421
PLoS Genet. 2017 Jun 8;13(6):e1006838
pubmed: 28594826
Science. 2017 Nov 10;358(6364):785-789
pubmed: 29123067
Syst Biol. 2015 Nov;64(6):1032-47
pubmed: 26227865
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7897-7904
pubmed: 32229557
PLoS Pathog. 2013;9(12):e1003800
pubmed: 24385900
PLoS Comput Biol. 2007 Feb 16;3(2):e29
pubmed: 17305421
PLoS Pathog. 2015 Jun 11;11(6):e1004847
pubmed: 26066799
Science. 2021 Oct 22;374(6566):488-492
pubmed: 34672730
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555
Mol Biol Evol. 2001 Dec;18(12):2298-305
pubmed: 11719579
Viruses. 2018 Jun 01;10(6):
pubmed: 29857590
Emerg Infect Dis. 2011 Apr;17(4):699-701
pubmed: 21470464
Elife. 2014 Aug 26;3:e03497
pubmed: 25161196
J Mol Evol. 1985;22(2):160-74
pubmed: 3934395
PLoS Pathog. 2012 Sep;8(9):e1002917
pubmed: 23028317
Mol Biol Evol. 2008 Jul;25(7):1459-71
pubmed: 18408232
Viruses. 2018 Jun 30;10(7):
pubmed: 29966329
mBio. 2011 Feb 08;2(1):e00334-10
pubmed: 21304168
Science. 2004 Jan 16;303(5656):327-32
pubmed: 14726583
Emerg Infect Dis. 2019 May;25(5):856-864
pubmed: 31002075
PLoS Negl Trop Dis. 2015 Jun 25;9(6):e0003817
pubmed: 26110870
Appl Environ Microbiol. 2005 Aug;71(8):4645-54
pubmed: 16085859
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
Virus Evol. 2016 Mar 02;2(1):vew003
pubmed: 27774296
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1702-7
pubmed: 15653771
Science. 2021 Jul 30;373(6554):
pubmed: 34326207
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1627-1632
pubmed: 30635420

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH